SCHEMBL114563

SCHEMBL114563

CCOc1ccc(-c2ccccc2N2CCN(C(C=O)n3nc(C)cc3C)CC2)cn1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CXCR3 P49682 1/20 0.42
KCNH2 Q12809 1/20 0.42
HTR1A P08908 5/20 0.35
HTR7 P34969 5/20 0.35
SMN1; SMN2 Q16637 3/20 0.33
LMNA P02545 2/20 0.33
CACNA1B Q00975 1/20 0.33
USP2 O75604 1/20 0.33
POLB P06746 1/20 0.33
HSP90AA1 P07900 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
KDM4E B2RXH2 1/20 0.32
FFAR2 O15552 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
PIK3CA P42336 1/20 0.31
GCK P35557 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL115324 0.91 KCNH2 (0.41) CXCR3KCNH2HTR1AHTR7PIK3CA
SCHEMBL114135 0.89 CXCR3 (0.41) CXCR3KCNH2HTR1AHTR7SMN1; SMN2
SCHEMBL115477 0.85 CXCR3 (0.42) CXCR3KCNH2HTR1AHTR7USP2
SCHEMBL114268 0.84 CXCR3 (0.40) CXCR3KCNH2HTR1AHTR7USP2
SCHEMBL113986 0.84 CXCR3 (0.40) CXCR3KCNH2HTR7LMNAMAPT
SCHEMBL115833 0.83 CXCR3 (0.41) CXCR3KCNH2POLBPIK3CA
SCHEMBL115566 0.83 KCNH2 (0.40) CXCR3KCNH2HTR1AHTR7PIK3CA
SCHEMBL115507 0.83 CXCR3 (0.40) CXCR3KCNH2MAPT
SCHEMBL113252 0.83 CXCR3 (0.41) CXCR3KCNH2HTR7MAPTPIK3CA
SCHEMBL113545 0.82 CXCR3 (0.42) CXCR3KCNH2HTR7MAPTPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424840-A1 CXCR3 RECEPTOR ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-03-07 EP disclosed
WO-2010126811-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-04 WO disclosed